Chronic low-grade adipose tissue and liver inflammation is a major cause of systemic insulin resistance and is a key component of the low degree of insulin sensitivity that exists in obesity and type 2 diabetes 1,2 . Immune cells, such as macrophages, T cells, B cells, mast cells and eosinophils, have all been implicated as having a role in this process [3] [4] [5] [6] [7] [8] . Neutrophils are typically the first immune cells to respond to inflammation and can exacerbate the chronic inflammatory state by helping to recruit macrophages and by interacting with antigen-presenting cells [9] [10] [11] . Neutrophils secrete several proteases, one of which is neutrophil elastase, which can promote inflammatory responses in several disease models 12 .
Here we show that treatment of hepatocytes with neutrophil elastase causes cellular insulin resistance and that deletion of neutrophil elastase in high-fat-diet-induced obese (DIO) mice leads to less tissue inflammation that is associated with lower adipose tissue neutrophil and macrophage content. These changes are accompanied by improved glucose tolerance and increased insulin sensitivity. Taken together, we show that neutrophils can be added to the extensive repertoire of immune cells that participate in inflammation-induced metabolic disease.
Compared to adipose tissue from nonobese mice fed a standard chow diet, adipose tissue from DIO mice has a markedly higher number of proinflammatory, M1-like macrophages that secrete cytokines such as tumor necrosis factor α (Tnf-α), interleukin-1β (Il-1β) and Il-6, which can directly lead to a lowered insulin sensitivity 1 . Although the role of tissue macrophages in this process has been well documented, recent studies have also indicated contributions from several other immune cell types, including T cells [3] [4] [5] , B cells 6 , mast cells 7 and eosinophils 8 .
Granulocytes comprise 60-70% of blood leukocytes, and more than 90% of granulocytes are neutrophils, making up the largest fraction of white blood cells. Feeding a high-fat diet (HFD) to mice causes an increase in neutrophil recruitment to adipose tissue 13 . Consequently, it is possible that neutrophils could have a role in initiating the inflammatory cascade in response to obesity. Adipose tissue neutrophils (ATNs) produce chemokines and cytokines, thereby facilitating macrophage infiltration, which could contribute to the chronic low-grade inflammation that characterizes obesity-induced insulin resistance.
In addition to host defense, neutrophil-derived serine proteases, such as neutrophil elastase, have also been implicated in sterile inflammation 12 . Therefore, we asked whether neutrophils contribute to the etiology of inflammation-induced insulin resistance and whether neutrophil elastase has a mechanistic role in this process.
We determined the time course of neutrophil infiltration in adipose tissue of C57BL/6J mice maintained on a 60% HFD starting at 8 weeks of age using fluorescence-activated cell sorting (FACS) analyses to identify adipose tissue stromal vascular cells (SVCs) positive for the neutrophil markers Ly6g and Cd11b and negative for the macrophage markers F4/80 and Cd11c. We refer to these cells as ATNs. Consistent with a previous report 13 , we detected a rapid increase in ATN content after 3 d of HFD feeding, and we also found that this increase was maintained for up to 90 d of an HFD regimen (Fig. 1a) . Immunohistochemistry (IHC) studies also showed a higher content of Ly6g + Cd11b + cells in the white adipose tissue (WAT) of the DIO mice compared to chowfed mice (Fig. 1b) . Consistent with the IHC results, our FACS analysis showed a 20-fold higher number of Cd11b + Ly6g + F4/80 − Cd11c − cells in SVCs of mice fed the HFD compared to the chow-fed mice ( Fig. 1c and Supplementary Fig. 1a) .
Expression of neutrophil elastase is higher in adipose tissue of DIO mice than in that from chow-fed mice (Supplementary Fig. 1c ). The expression of neutrophil elastase increased after only 3 d of HFD and remained elevated after 12 weeks of HFD (Fig. 1d) , which is comparable to the pattern of increased ATN content seen in DIO mice. Consistent with the increases in ATN content and neutrophil elastase expression after HFD feeding, neutrophil elastase activity was also markedly higher in mice after 12 weeks of HFD compared to mice at the same time point fed standard chow ( Fig. 1e and Supplementary  Fig. 2 ). Wild-type (WT) DIO mice treated with the neutrophil elastase inhibitor GW311616A 14 at a dose of 2 mg per kg of body weight of the mice per day for 14 d showed substantially improved glucose tolerance ( Fig. 1f) with no change in body weight (Supplementary Fig. 3a) .
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase Treatment with GW311616A also lessened the severity of HFDinduced glucose intolerance when administered for 14 d (2 mg per kg of body weight of the mice per day) beginning at the start of HFD feeding compared to mice administered vehicle (Supplementary Fig. 3c ). In contrast, treatment with recombinant mouse neutrophil elastase (1 mg per kg of body weight of the mice per day for 7 d) of chow-fed mice led to markedly higher glucose intolerance in the treated mice compared to that in untreated mice (Fig. 1g) .
Based on these treatment results and the fact that the number of ATNs was higher in DIO mice than in chow-fed mice, we studied mice carrying a genetic deletion of neutrophil elastase (B6.129X1-Elane tm1Sds /J, referred to here as NEKO). On an HFD, we found that the NEKO mice gained somewhat less weight compared to WT mice ( Supplementary Fig. 4a ), which was consistent with their modestly higher core temperature (Supplementary Fig. 4b ) and oxygen consumption (Supplementary Fig. 4c ). Liver weight was substantially lower and WAT weight was substantially higher in NEKO mice compared to WT mice, both in absolute amounts and when expressed as a percentage of body weight (Supplementary Fig. 4d ). After 10 weeks of HFD feeding, we performed glucose tolerance tests (GTTs) in NEKO mice and used age-and weight-matched WT mice on the same diet as controls. The NEKO mice had markedly higher glucose tolerance (Fig. 1h) and lower fasting insulin concentrations compared to WT mice (Supplementary Fig. 4e) . Consistent with the GTT results, insulin tolerance tests (ITTs) showed that the NEKO mice were substantially more sensitive to insulin than the WT mice (Fig. 1i) .
ATN content was ~90% lower in the NEKO mice compared to the WT mice on HFD (Fig. 1j) . In addition, WT DIO mice treated with the neutrophil elastase inhibitor also showed a marked decrease in ATN content compared to WT DIO mice treated with vehicle (Fig. 1j) . Thus, both genetic and pharmacologic loss of function of neutrophil elastase produced improved glucose tolerance with less ATNs, whereas pharmacologic gain of function led to glucose intolerance.
To quantify the overall magnitude of the insulin sensitivity and to determine tissue-specific contributions, we performed hyperinsulinemiceuglycemic clamp studies. The glucose infusion rate that was required to maintain euglycemia was higher in NEKO mice compared to WT mice (Fig. 2a) . There were no differences in total glucose disposal rate (Fig. 2b) , insulin-stimulated glucose disposal rate (Fig. 2c) or basal hepatic glucose production (HGP) (Fig. 2d) between the two groups. However, insulin had a greater ability to inhibit HGP in the NEKO mice compared to the WT mice, as shown by the clamp HGP (Fig. 2e) and percentage of suppression of HGP (Fig. 2f) . Basal and clamp free fatty acid (FFA) concentrations were substantially lower in NEKO mice than in WT mice (Fig. 2g) , and the ability of insulin to suppress FFA concentrations was greater in NEKO mice than in WT mice (Fig. 2h) . Taken together, these results show that neutrophil elastase deletion leads to a high degree of hepatic and adipose tissue insulin sensitivity.
Next, we performed acute insulin response studies by intravenously injecting insulin and harvesting liver and epididymal WAT (eWAT) from the NEKO and WT mice. Consistent with the ex vivo glucose clamp npg studies, the biochemical measures of hepatic and adipose insulin signaling were higher in NEKO mice compared to WT mice, as evidenced by elevated insulin-stimulated phosphorylation of Akt (Fig. 2i) .
As studies have reported neutrophil infiltration of liver in obese humans with nonalcoholic steatohepatitis 15 , we assessed hepatic neutrophil content by IHC in our experimental mouse groups. Hepatic neutrophil content was higher in WT mice fed the HFD compared to those fed chow, with no elevation of neutrophil content found in the NEKO mice fed the HFD (Fig. 3a) . Hepatic neutrophil elastase activity was also higher in WT HFD-fed mice compared to WT leanchow-fed mice ( Fig. 3b and Supplementary Fig. 2) .
Previous reports have shown that extracellular neutrophil elastase can gain access to the intracellular space and mediate degradation of insulin receptor substrate 1 (Irs1) 16, 17 . Consistent with these reports, the concentration of Irs1 was higher in the liver (Fig. 3c ) and adipose tissue ( Supplementary Fig. 5d ) of NEKO mice compared to WT mice. Next, we investigated whether neutrophil elastase can inhibit hepatic Irs1-mediated insulin signaling. We administered neutrophil elastase (1 mg per kg body weight of the mice, 2 h apart) to 4-month-old fasted C57BL/6J mice. Two hours after the second dose, we performed an acute insulin response and harvested liver before and at 3 mins and 7 mins after insulin injection. Administration of neutrophil elastase in these mice caused a decrease in the levels of Irs1 in the liver (Fig. 3d) and of phosphorylated Akt (pAkt) in the basal and insulintreated states (Fig. 3e) . The level of Irs1 in the eWAT from these neutrophil elastase-treated mice was also substantially lower than that in vehicle-treated control mice (Supplementary Fig. 5a ). In contrast, Irs1 expression was higher in the liver (Fig. 3c) and adipose tissue (Supplementary Fig. 5d ) of NEKO mice compared to WT mice.
Next, we added neutrophil elastase directly to primary mouse ( Fig. 3f ) and primary human hepatocytes (Fig. 3g) and found a marked decrease in Irs1 protein content in both cell types, which is consistent with enhanced degradation. This lowering of Irs1 protein content resulted in reduced insulin-stimulated Akt phosphorylation in mouse (Fig. 3h) and human (Fig. 3i) hepatocytes. Although our data showed lower Irs1 protein content in hepatocytes after treatment with neutrophil elastase, it is unclear whether this is the result of a direct intracellular or an indirect extracellular effect of the protease.
To determine whether these changes in hepatocyte insulin signaling resulted in biological effects, we measured glucose output in primary mouse hepatocytes with and without neutrophil elastase treatment (Fig. 3j) . Glucagon treatment leads to a near twofold increase in primary hepatocyte glucose output, and insulin treatment suppresses this output to basal values. In the absence of glucagon, neutrophil elastase treatment stimulated basal glucose output by 50%, and insulin did not inhibit this effect (Fig. 3j) . More notably, neutrophil elastase treatment largely prevented the ability of insulin to inhibit glucagon-stimulated hepatocyte glucose output. Thus, neutrophil elastase causes Irs1 degradation, lower insulin signaling, higher glucose production and cellular insulin resistance in primary mouse and human hepatocytes.
We also measured mRNA levels of liver lipogenic and cholesterol synthesis genes and found that Acc, Fas, Scd, Hmgcr and Hmgcs1 (Hmgcs) were markedly lower, whereas PpargC1a (PGC1a) and Nrf1 (Nrf) were higher, in livers from NEKO mice compared to livers from WT mice. There was no difference in the mRNA abundance of Srebpf1 (Srebp1c), Pepck, G6pc (G6Pase) or Cpt1a mRNA between NEKO and WT mice (Supplementary Fig. 6a ). To confirm that decreased lipogenic gene expression resulted in functional changes in lipogenesis, we measured the incorporation of 14 C-actetate into liver lipids in the NEKO and WT mice. The total amount of 14 C-acetate incorporation (Supplementary Fig. 6b ) and the rate of 14 C-acetate incorporation (Supplementary Fig. 6c ) into liver lipids were substantially lower in NEKO mice compared to the WT mice.
As we found better adipose tissue insulin signaling in NEKO mice compared to WT mice (Fig. 2i) , we treated 3T3-L1 adipocytes with recombinant mouse neutrophil elastase. The results showed that this treatment led to decreased Irs1 protein content ( Supplementary  Fig. 5b ) and impaired insulin-stimulated phosphorylation of Akt in a dose-dependent manner (Supplementary Fig. 5c ).
Because previous reports have shown that neutrophil elastase can activate Toll-like receptor 4 (Tlr4), resulting in an increase of proinflammatory factors 12,18-20 , we used intraperitoneal macrophages (IP-macs) from WT and Tlr4 knockout (Tlr4KO) mice and treated them with lipopolysaccharide (LPS) and recombinant mouse neutrophil elastase. Treatment with LPS caused increased abundances of Tnfa, Il1b, Cxcl1 (KC) and Il6 mRNA in WT but not Tlr4KO IPmacs. Similar to LPS, treatment with recombinant neutrophil elastase caused higher mRNA abundance of Tnfa, Il1b, Cxcl1 (KC) and Il6 in WT but not Tlr4KO IP-macs, showing that the proinflammatory effects of neutrophil elastase are dependent on Tlr4 (Fig. 4a) , which is consistent with previous reports 12, [18] [19] [20] . The mRNA abundance of proinflammatory markers such as Tnfa, Emr1 (F4/80), Cxcl1 (KC), Il1r1, Il1b and Ccl2 (Mcp1) were substantially lower and the mRNA abundance of the anti-inflammatory marker Arginase was higher in NEKO mouse liver compared to WT liver (Fig. 4b) . Consistent with this lower proinflammatory mRNA abundance, the amount of npg degradation of nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor, β (IκB), was lower in NEKO mice than in WT mice (Fig. 4b) .
In adipose tissue, the mRNA abundance of Il1b, Tnfa, Cxcl1 (KC), Cd68, Irf4 and Irf5 were lower, and the mRNA abundance of Arg, Clec10a (Mgl1) and Il4 were higher, in NEKO mice compared to WT mice (Fig. 4c) . The amount of degradation of IκB was also lower in NEKO mice than in WT mice (Fig. 4c) . To determine the contribution of adipocytes compared to immune cells to these changes in mRNA abundance, we isolated SVCs and adipocytes from WT and NEKO mice and found that each fraction had lower expression of inflammatory markers in NEKO mice compared to WT mice ( Supplementary  Fig. 7a ). FACS analyses for adipose tissue macrophage (ATM) content showed that the number of Cd11c + M1-like cells was lower (Fig. 4d) , whereas the number of F4/80 + Cd11b + Cd11c − (also known as M2-like) cells was higher, in NEKO mice compared to WT mice (Fig. 4e) . This suggests that elastase secreted from neutrophils has a role in recruiting these cells to adipose tissue and, possibly, in their polarization state. For example, neutrophil elastase functions as an activator of Tlr4 (refs. 12,18-20), and stimulation of the Tlr4 proinflammatory pathway leads to increased chemokine release from a variety of adipose tissue cell types, including adipocytes and macrophages 1,2 . Consistent with changes in inflammatory tone in liver and adipose tissue, serum concentrations of Il-1β, Tnf-α, chemokine (C-C motif) ligand 2 (Ccl2, also known as Mcp-1), Il-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), Ccl3 (Mip1-α), Ccl4 (Mip1-β) (Fig. 4f) and resistin (Supplementary Fig. 7b ) were lower in NEKO mice compared to WT mice.
Gene expression analyses of adipose tissue revealed that the abundances of Acc, Fas, Lipe (Hsl), Pnpla2 (Atgl) and Slc2a4 (Glut4) mRNA were markedly higher in NEKO mice than in WT mice (Supplementary Fig. 7c ). We excised fat pads from the NEKO and WT mice and measured glucose uptake by measuring the levels of 2-deoxyglucose (2-DOG), and both basal and insulin-stimulated glucose uptake were higher in NEKO mice than in WT mice (Fig. 4g) , which is consistent with the in vivo and in vitro data showing greater adipose insulin sensitivity in the NEKO mice.
In these studies, we show a sustained higher neutrophil content in adipose tissue and liver in DIO mice. As neutrophils are known to have a role in the early stages of inflammatory responses, it is probable Shown is a representative graph generated from data from one of at least three independent experiments. (i) Quantification by MSD of total AKT and pAKT in protein harvested from primary human hepatocytes treated with human neutrophil elastase for 6 h and spiked with insulin for 5 min to obtain insulin induction. The graph was generated with data from at least two independent experiments performed in triplicate. *P < 0.05 by two-way ANOVA and Bonferroni's post test. (j) Representative glucose output assay in primary mouse hepatocytes from at least three independent experiments performed in duplicate or triplicate. *Significantly (P < 0.05) higher than basal, # significantly (P < 0.05) higher than insulin and glucagon by Student's t test. C.p.m., counts per million. Error bars (b-j), s.e.m.
npg l e t t e r s nature medicine VOLUME 18 | NUMBER 9 | SEPTEMBER 2012 1 4 1 1 that neutrophils participate in the inflammation that characterizes obesity. Furthermore, secreted elastase from neutrophils is the key effector in this process. Consistent with this, we find that addition of neutrophil elastase to hepatocytes or adipocytes causes cellular insulin resistance, and, in the context of HFD-induced obesity, NEKO mice were protected from adipose tissue and liver inflammation, with a corresponding high degree of insulin sensitivity in adipose tissue and hepatocytes. We also treated WT DIO mice with a small-molecule neutrophil elastase inhibitor and found that this compound improved glucose tolerance in these mice. It is of interest that inhibition or knockout of neutrophil elastase results in decreased ATN content. One possible mechanism for this is that since neutrophil elastase activates the Tlr4 pathway, it could cause chemokine release from immune cells and/or adipocytes causing a feedforward secondary mechanism of ATN recruitment. Also, as we have demonstrated, neutrophil elastase inhibition improves insulin resistance and this could lead to less chemokine release from adipocytes.
In addition to macrophages, a variety of immune cells, such as lymphocytes, eosinophils and mast cells, have been shown to participate in the complex intracellular communication network that organizes the chronic inflammatory response of obesity. Based on our studies of chronic HFD mice and those of others 13 showing the presence of ATNs after acute HFD feeding, we suggest that neutrophils should be considered active participants in the immune-cell-type conversation, which ultimately leads to obesity-induced inflammation and insulin resistance.
MeTHODs
Methods and any associated references are available in the online version of the paper. 
ONLINe MeTHODs
Mice. NEKO (JAX labs, B6.129X1-Elane tm1Sds /J, 006112), and WT C57BL/6J (000664) mice were obtained from JAX. Only male mice were used in this study. We placed NEKO and age-matched WT mice on a 60% HFD (D12492, Research Diets) for 12 weeks and monitored their body weight and food intake. For weight-matched controls, we used WT mice on a 60% HFD (D12492) that were about 2-3 weeks younger than the NEKO mice. We housed all mice according to UCSD and Institutional Animal Care and Use Committeeapproved protocols. All mouse procedures conformed to the Guide for Care and Use of Laboratory Animals of the US National Institutes of Health and were approved by the Animal Subjects Committee of UCSD.
Metabolic studies. For ITT and GTTs, we fasted mice for 7 h. For GTT, we administered an intrapertioneal (i.p.) dose of 1 g kg −1 dextrose and measured blood glucose concentrations at the indicated time points. We measured fasting insulin after 6 h of fasting on the day of GTT. For ITT, we used an i.p. dose of 0.6 U kg −1 insulin and measured blood glucose concentrations at the indicated time points.
We performed hyperinsulinemic-euglycemic clamp studies as previously described 21 . We only used mice that lost <4% of their precannulation weight after 4-5 d of recovery. We administered a constant infusion (5 µCi h −1 ) of D- [3-3H] glucose (DuPont-NEN) 6 h after fasting. After 90 min of tracer equilibration and basal sampling, we infused 50% dextrose (Abbott) and tracer (5 µCi h −1 ) plus insulin (6 mU kg −1 min −1 ) in the jugular vein cannula. We sampled blood from tail clips at 10-min intervals, and steady-state conditions (120 mg dl −1 ± 5 mg dl −1 ) were achieved at the end of the clamp by maintaining glucose infusion and plasma glucose concentration for a minimum of 20 min.
Acute insulin response. We fasted mice either overnight or for 7 h. We performed this procedure on WT and NEKO mice on an HFD at an insulin dose of 0.35 U kg −1 . We also performed this procedure on WT C57BL/6J mice on a chow diet injected with vehicle and recombinant mouse neutrophil elastase (4517-SE) at a submaximal insulin dose of 0.1 U kg −1 . Briefly, we anesthetized mice, suture sealed a small lobe of the liver to prevent bleeding and excised it. We also obtained an eWAT biopsy and flash froze it in liquid nitrogen. These samples are referred to here as 'basal' . We injected insulin at the above-mentioned dose into the inferior vena cava and obtained tissue biopsies as described at the indicated time points and flash froze them in liquid nitrogen. We prepared lysates and ran western blots or MSD according to standard protocol.
Indirect calorimetry and core temperature. We performed indirect calorimetry between week 7 and 8 of HFD, as previously described 22 . We individually housed mice in metabolic cages for measurements. We allowed all mice to adapt to the new environment for 48 h before beginning the study. We normalized oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) with respect to body weight. We calculated energy expenditure based on the formula: energy expenditure = 3.815 × VO 2 + 1.232 × VCO 2 .
We measured the core temperature of the mice by insertion of a rectal probe and took all temperature measurements under fed conditions at about 3 p.m. We took the temperature measurements at between 8 and 9 weeks of HFD feeding.
Western blotting and gene expression analyses. We performed western blotting as previously described 23 . All antibodies used were from Cell Signaling Technology. We performed qPCR as previously described 24 .
FACS analyses. We weighed epididymal fat pads rinsed in PBS and then minced in FACS buffer (PBS containing 1% BSA). We prepared adipocytes and SVCs from collagenase-digested adipose tissue. We performed FACS analysis of SVCs for macrophage content and subtypes, as described 21 , and the estimation of macrophage subsets numbers per gram of fat was performed as previously described 21 . We incubated stromal vascular cells with Fc Block (BD Biosciences, San Jose, CA) for 20 min at 4 °C before staining with fluorescently labeled primary antibodies, and no stain, single stains and fluorescence minus one controls were used for setting compensation and gates. We purchased the neutrophil marker Ly6g antibody from BD Biosciences (1A8). We used the Ly6g antibody at 4 µg/ml for 30 min at 4 °C.
Confocal microscopy of mouse adipose tissue. We excised fingernail-sized fat pad samples and blocked them for 1 h in 5% BSA in PBS with gentle rocking at room temperature. For the detection of intracellular antigens, blocking and subsequent incubations were done in 5% BSA in PBS with 0.3% Triton X-100. We diluted primary antibodies in blocking buffer to 0.5-1 mg ml −1 and added them to the fat samples overnight at 4 °C. After three washes, we added fluorochrome-conjugated secondary antibodies for 1 h at room temperature. We imaged fat pads on an inverted confocal microscope (Olympus Fluoview 1000). The mouse-specific antibodies used were to Cd11b (M1/70, Abcam, 1:500), caveolin (BD Biosciences, 610060, 1:500) and Ly6g (1A8, BD Biosciences, 1:100).
Lipogenesis in liver explants. We quickly sliced liver samples into chunks of approximately 1-to 2-mm and transferred them into wells containing 0.5 ml phosphate salt bicarbonate buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 4 mM KCl, 125 mM NaCl, 0.85 mM KH 2 PO 4 , 1.25 m Na 2 HPO 4 , 1 mM MgCl 2 , 1 mM CaCl 2 and 15 mM NaHCO 3 ) containing 0.5% fatty-acid-free BSA and 0.2 mM unlabeled sodium acetate in 12-well culture plates and incubated them for 30 min. We added 1 µCi 2-14 C-acetate to each well and incubated the plates for 60 min at 37 °C in a 5% CO 2 incubator. We terminated incubation by adding 0.5 ml of 2 N HCl to each well. We transferred explants with the incubation buffer to 5-ml polyethylene tubes, centrifuged them and removed the supernatants. Next, we added 0.5 ml 1 N HCl to each tube and homogenized the explant suspensions, which we followed with the addition of 1.5 ml of a mixture of chloroform and methanol (2:1) to each homogenate. We vortexed the tubes to obtain a monophasic mixture. Next, 0.5 ml chloroform and 0.5 ml 1 M NaCl were added to the homogenates, and the tubes were vortexed and centrifuged to obtain separate two layers. We collected the lower chloroform layer, evaporated it and counted for the incorporation of labeled acetate into lipids. We saved an aliquot of the homogenates for a protein assay before adding an organic solvent cocktail. The specific activity in the incubation was 22,000 c.p.m. nmol −1 acetate.
Glucose uptake in adipose explants. We quickly sliced adipose tissue samples into 1-to 2-mm sizes. Adipose explants prepared from half of each epididymal fat pad were taken into wells containing 0.5 ml phosphate salt bicarbonate buffer (10 mM HEPES, 4 mM KCl, 125 mM NaCl, 0.85 mM KH 2 PO 4 , 1.25 mM Na 2 HPO 4 , 1 mM MgCl 2 , 1 mM CaCl 2 and 15 mM NaHCO 3 ) containing 0.5% fatty-acid-free BSA in 12-well culture plates. We incubated plates for 15 min in a 5% CO 2 incubator at 37 °C. We added insulin to some wells at a final concentration of 17 nM and incubated the plates for an additional 30 min. Next, we added 0.2 µCi 3 H-2-deoxyglucose (final concentration 0.1 mM) to each well and incubated the plates for 10 min at 37 °C in a 5% CO 2 incubator. We terminated the incubation by placing the plates on an ice tray followed by the addition of cytochalasin B (final concentration 0.01 mM) to stop further uptake. We carefully removed the radiolabeled buffer, avoiding pieces of the explants, and washed the explants three times with chilled PBS. Next, we added 0.5 ml of 1 N NaOH to each well, and the plates were shaken for 30 min at room temperature. We transferred the alkaline suspensions to 5-ml culture tubes and homogenized them. We saved an aliquot for protein assay and transferred the rest of the homogenate to 10-ml scintillation vials. We neutralized the alkaline homogenates, with 0.5 ml 1 N HCl added into the vials, and counted radioactivity using a 10-ml scintillation cocktail.
IP-mac isolation and culture. We harvested IP-macs from WT and Tlr4 knockout mice, as previously described 21 . Three days after harvest and plating, we treated cells with 100 nM recombinant mouse neutrophil elastase (R&D Systems, 4517S E) and LPS (100 ng ml −1 ) for 6 h before RNA isolation and qPCR analyses. We used heat-inactivated neutrophil elastase as a control treatment.
Human hepatocytes culture. We used primary cryopreserved plateable human hepatocytes in this experiment from BD Bioscience (310) and used npg
